Alioth Guerrero-Aranda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alioth Guerrero-Aranda has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Andrea Enríquez-Zaragoza
Epilepsy Clinic, Hospital “Country 2000,” Guadalajara, Jalisco, México
4 shared publicationsAndrés Antonio González-Garrido
Department of Clinical Neurophysiology, Grupo RIO, Guadalajara, Jalisco, México
3 shared publications- Brenda Vega-Ruiz
Departamento de Ciencias de la Salud, Centro Universitario de los Valles (CUValles), Universidad de Guadalajara, Carr. a Guadalajara Km. 45.5, Ameca 46600, Jalisco, Mexico
3 shared publications Francisco J. Taveras-Almonte
Department of Neurology, Professional Towers “Corazones Unidos,” Santo Domingo, República Dominicana
3 shared publicationsFridha V. Villalpando-Vargas
Epilepsy Clinic, Hospital “Country 2000,” Guadalajara, Jalisco, México
3 shared publications- Fridha Viridiana Villalpando-Vargas
Departamento de Ciencias de la Salud, Centro Universitario de los Valles (CUValles), Universidad de Guadalajara, Carr. a Guadalajara Km. 45.5, Ameca 46600, Jalisco, Mexico
3 shared publications
Latest Publications
- Open Access
Bee Venom-Loaded Nanoliposomes: In Vitro Antioxidant and Erythroprotective Activities and Behavior During Simulated Gastrointestinal Digestion
The behavior of bee venom-loaded nanoliposomes (BV-LNs) during gastrointestinal digestion remains insufficiently characterized. This study evaluated their physicochemical properties, antioxidant responses, hemocompatibility, protection against AAPH-induced oxidative hemolysis, apparent in vitro transfer during dialysis, and responses to simulated gastrointestinal digestion. Antioxidant and erythrocyte responses were compared among free bee venom (BV), empty nanoliposomes, and BV-LNs; dialysis transfer was compared between free BV and BV-LNs, whereas simulated digestion was evaluated for BV-LNs. BV-LNs exhibited a hydrodynamic diameter of 132.00 ± 14.23 nm and a zeta potential of −33 ± 2 mV. DPPH and FRAP responses did not differ significantly between free BV and BV-LNs, whereas ABTS inhibition was significantly greater for BV-LNs (69.17 ± 1.06% vs. 55.72 ± 4.89%). BV-LNs showed greater antihemolytic activity than free BV at BV-equivalent concentrations of 10 and 40 µg/mL. However, direct hemocompatibility decreased with concentration and exposure time, with no consistent advantage for BV-LNs. BV-LNs also showed slower apparent transfer of BV-derived UV-absorbing material during dialysis. During simulated digestion, DPPH and ABTS inhibition were lowest in the gastric fraction and higher in the intestinal fractions. The dialyzed intestinal fraction showed measurable DPPH (42.84 ± 2.14%) and ABTS (25.39 ± 2.47%) inhibition and antihemolytic activity in A, B, and O RhD-positive erythrocytes. These findings demonstrate formulation-associated differences in antioxidant and antihemolytic responses, with activity remaining detectable after digestion and dialysis. They do not establish controlled release, preservation of intact venom peptides, improved digestive stability relative to free BV, intestinal absorption, or a general safety advantage.
Open AccessBee Venom-Loaded Nanoliposomes: In Vitro Antioxidant and Erythroprotective Activities and Behavior During Simulated Gastrointestinal Digestion
The behavior of bee venom-loaded nanoliposomes (BV-LNs) during gastrointestinal digestion remains insufficiently characterized. This study evaluated their physicochemical properties, antioxidant responses, hemocompatibility, protection against AAPH-induced oxidative hemolysis, apparent in vitro transfer during dialysis, and responses to simulated gastrointestinal digestion. Antioxidant and erythrocyte responses were compared among free bee venom (BV), empty nanoliposomes, and BV-LNs; dialysis transfer was compared between free BV and BV-LNs, whereas simulated digestion was evaluated for BV-LNs. BV-LNs exhibited a hydrodynamic diameter of 132.00 ± 14.23 nm and a zeta potential of −33 ± 2 mV. DPPH and FRAP responses did not differ significantly between free BV and BV-LNs, whereas ABTS inhibition was significantly greater for BV-LNs (69.17 ± 1.06% vs. 55.72 ± 4.89%). BV-LNs showed greater antihemolytic activity than free BV at BV-equivalent concentrations of 10 and 40 µg/mL. However, direct hemocompatibility decreased with concentration and exposure time, with no consistent advantage for BV-LNs. BV-LNs also showed slower apparent transfer of BV-derived UV-absorbing material during dialysis. During simulated digestion, DPPH and ABTS inhibition were lowest in the gastric fraction and higher in the intestinal fractions. The dialyzed intestinal fraction showed measurable DPPH (42.84 ± 2.14%) and ABTS (25.39 ± 2.47%) inhibition and antihemolytic activity in A, B, and O RhD-positive erythrocytes. These findings demonstrate formulation-associated differences in antioxidant and antihemolytic responses, with activity remaining detectable after digestion and dialysis. They do not establish controlled release, preservation of intact venom peptides, improved digestive stability relative to free BV, intestinal absorption, or a general safety advantage.
- Open Access
- 7 September 2026
- Published by MDPI AG in Preprints.org
Bee Venom-Loaded Nanoliposomes as an Antioxidant and Erythroprotective Delivery Platform for In Vitro Controlled Release and Improved Gastrointestinal Stability
Bee venom (BV) contains bioactive peptides with potent antioxidant, anti-inflammatory, and neuroprotective properties, yet its direct therapeutic use is limited by cytotoxicity, instability, and uncontrolled release. This study aimed to develop and evaluate bee venom-loaded nanoliposomes (BV-LN) as an innovative Antioxidant and erythroprotective delivery platform with controlled in vitro release and enhanced gastrointestinal stability for potential applications in neurodegenerative disease management. BV’s antioxidant activity, erythroprotective potential, hemocompatibility, and membrane-stabilizing capacity were systematically assessed, alongside assays for antihemolytic activity against AAPH-induced oxidative hemolysis. BV-LN were synthesized via thin-film hydration and extensively characterized for encapsulation efficiency (84.43 ± 2.26%), water solubility (1.83 µg/mL), centrifugal stability (94.13 ± 3.53%), morphological integrity, and thermal/structural properties (XRD, DSC). Simulated digestion tests confirmed gradual peptide release under gastric and intestinal conditions. Results highlight BV’s strong antioxidant activity (≈70% DPPH inhibition) and marked erythroprotective effects, including >98% hemocompatibility at safe concentrations and significant membrane stabilization under heat and osmotic stress. Encapsulation in nanoliposomes slightly modulated immediate radical scavenging but enhanced safety by preventing excessive hemolysis and enabling controlled melittin release. The robust nanoliposomal structure, driven by peptide–phospholipid hydrophobic anchoring and cholesterol-mediated bilayer ordering, ensured stability under mechanical and digestive stress. This research is highly innovative as it pioneers BV encapsulation for neuroprotective nutraceutical applications, offering a safe, sustained-release platform that could mitigate oxidative stress and inflammation, key drivers of disorders like epilepsy, Alzheimer’s, and Parkinson’s. BV-LN demonstrate strong potential as next-generation carriers for functional foods or therapeutic formulations targeting neurodegenerative diseases, warranting further in vitro validation and translational studies.
- 7 September 2026
- Published by MDPI AG in Preprints.org
Open AccessBee Venom-Loaded Nanoliposomes as an Antioxidant and Erythroprotective Delivery Platform for In Vitro Controlled Release and Improved Gastrointestinal Stability
Bee venom (BV) contains bioactive peptides with potent antioxidant, anti-inflammatory, and neuroprotective properties, yet its direct therapeutic use is limited by cytotoxicity, instability, and uncontrolled release. This study aimed to develop and evaluate bee venom-loaded nanoliposomes (BV-LN) as an innovative Antioxidant and erythroprotective delivery platform with controlled in vitro release and enhanced gastrointestinal stability for potential applications in neurodegenerative disease management. BV’s antioxidant activity, erythroprotective potential, hemocompatibility, and membrane-stabilizing capacity were systematically assessed, alongside assays for antihemolytic activity against AAPH-induced oxidative hemolysis. BV-LN were synthesized via thin-film hydration and extensively characterized for encapsulation efficiency (84.43 ± 2.26%), water solubility (1.83 µg/mL), centrifugal stability (94.13 ± 3.53%), morphological integrity, and thermal/structural properties (XRD, DSC). Simulated digestion tests confirmed gradual peptide release under gastric and intestinal conditions. Results highlight BV’s strong antioxidant activity (≈70% DPPH inhibition) and marked erythroprotective effects, including >98% hemocompatibility at safe concentrations and significant membrane stabilization under heat and osmotic stress. Encapsulation in nanoliposomes slightly modulated immediate radical scavenging but enhanced safety by preventing excessive hemolysis and enabling controlled melittin release. The robust nanoliposomal structure, driven by peptide–phospholipid hydrophobic anchoring and cholesterol-mediated bilayer ordering, ensured stability under mechanical and digestive stress. This research is highly innovative as it pioneers BV encapsulation for neuroprotective nutraceutical applications, offering a safe, sustained-release platform that could mitigate oxidative stress and inflammation, key drivers of disorders like epilepsy, Alzheimer’s, and Parkinson’s. BV-LN demonstrate strong potential as next-generation carriers for functional foods or therapeutic formulations targeting neurodegenerative diseases, warranting further in vitro validation and translational studies.
- Open Access
- 9 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 729
Epilepsy Surgery in a Resource-Limited Latin-American Center: Presurgical Evaluation Findings and Early ILAE Outcomes in a Mixed Adult-Pediatric Cohort
Background: Resource-constrained programs perform epilepsy surgery under limited access to advanced imaging and neuromodulation. We describe presurgical evaluation findings, early seizure outcomes, and safety from a mixed adult-pediatric cohort. Methods: Retrospective single-center series of 22 consecutive patients meeting surgical candidacy. We captured demographics, epilepsy classification/etiology, presurgical investigations (long-term Video-EEG, MRI, selective FDG-PET), procedure type, histopathology when available, and postoperative seizure outcome (ILAE). Complications were recorded using the ILAE adverse-event taxonomy. Results: Mean age at surgery was 21.2 ± 11.2 years; 15 (68%) were male. Epilepsy was focal in 15 (68%); structural etiologies predominated in 15 (68%). MRI was concordant with the presumed epileptogenic zone in 13 (59%). FDG-PET was obtained in 10 (45.5%) and was concordant in 7 (70%). Long-term Video-EEG (≥2 habitual seizures) was completed in 21. Mean delay to surgery was 10 years (IQR [8–15]); presurgical work-up averaged 10 months (IQR [6–15]). Procedures were resective 14 (64%), disconnective 6 (27%), and neuromodulatory 2 (9%). Histopathology was available in 16 cases, most commonly showing hippocampal sclerosis (n = 5) and focal cortical dysplasia (n = 5). At 14 months median follow-up (range 12–34), ILAE outcomes were: I 41% (9), II 14% (3), III 23% (5), IV 23% (5). Outcomes significantly differed by procedure: curative-intent (resection/disconnection) achieved ILAE I 60% (9) versus ILAE III/IV 7 after palliative-intent (corpus callosotomy/neuromodulation). No deaths or permanent deficits occurred; one corpus callosotomy case developed transient aseptic meningitis. Conclusions: In a resource-limited program, structured presurgical evaluation and careful selection yield resection/disconnection outcomes comparable to high-resource benchmarks, while corpus callosotomy/neuromodulation remain largely palliative. Practical, reproducible pathways may help shorten delays and improve access in similar settings.
- 9 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 729
Open AccessEpilepsy Surgery in a Resource-Limited Latin-American Center: Presurgical Evaluation Findings and Early ILAE Outcomes in a Mixed Adult-Pediatric Cohort
Background: Resource-constrained programs perform epilepsy surgery under limited access to advanced imaging and neuromodulation. We describe presurgical evaluation findings, early seizure outcomes, and safety from a mixed adult-pediatric cohort. Methods: Retrospective single-center series of 22 consecutive patients meeting surgical candidacy. We captured demographics, epilepsy classification/etiology, presurgical investigations (long-term Video-EEG, MRI, selective FDG-PET), procedure type, histopathology when available, and postoperative seizure outcome (ILAE). Complications were recorded using the ILAE adverse-event taxonomy. Results: Mean age at surgery was 21.2 ± 11.2 years; 15 (68%) were male. Epilepsy was focal in 15 (68%); structural etiologies predominated in 15 (68%). MRI was concordant with the presumed epileptogenic zone in 13 (59%). FDG-PET was obtained in 10 (45.5%) and was concordant in 7 (70%). Long-term Video-EEG (≥2 habitual seizures) was completed in 21. Mean delay to surgery was 10 years (IQR [8–15]); presurgical work-up averaged 10 months (IQR [6–15]). Procedures were resective 14 (64%), disconnective 6 (27%), and neuromodulatory 2 (9%). Histopathology was available in 16 cases, most commonly showing hippocampal sclerosis (n = 5) and focal cortical dysplasia (n = 5). At 14 months median follow-up (range 12–34), ILAE outcomes were: I 41% (9), II 14% (3), III 23% (5), IV 23% (5). Outcomes significantly differed by procedure: curative-intent (resection/disconnection) achieved ILAE I 60% (9) versus ILAE III/IV 7 after palliative-intent (corpus callosotomy/neuromodulation). No deaths or permanent deficits occurred; one corpus callosotomy case developed transient aseptic meningitis. Conclusions: In a resource-limited program, structured presurgical evaluation and careful selection yield resection/disconnection outcomes comparable to high-resource benchmarks, while corpus callosotomy/neuromodulation remain largely palliative. Practical, reproducible pathways may help shorten delays and improve access in similar settings.
- Open Access
- 18 March 2026
- Published by Georg Thieme Verlag KG in International Journal of Epilepsy
The Need for Operational Criteria to Standardize Photoparoxysmal Response Interpretation: A Commentary
The photoparoxysmal response (PPR) is an epileptiform electroencephalographic (EEG) phenomenon triggered by intermittent photic stimulation. It is used to assess photosensitivity in individuals with epilepsy. However, wide variations in interpretation and inconsistent methodological practices have led to unreliable detection and classification of PPR, potentially affecting the management of photosensitive epilepsy. In regions with limited resources, the lack of standardized protocols, challenges with EEG equipment, and restricted access to specialized training further exacerbate diagnostic uncertainty. Despite multiple efforts to create guidelines for intermittent photic stimulation, the interpretation of PPR remains highly subjective, with only fair to moderate interrater agreement even among experienced specialists. One principal point of contention is differentiating truly stimulus-evoked activity from spontaneous epileptiform discharges. This ambiguity is clinically significant because determining photosensitivity influences lifestyle recommendations and treatment choices. Current classification systems for PPR establish broad categories of abnormal EEG activity, but they lack detailed operational criteria. There is no universal rule for the minimal duration of an abnormal discharge or the acceptable delay from stimulus onset. Additionally, narrowly incrementing photic stimulation frequencies may not always clarify borderline discharges. As a result, technicians and clinicians may prematurely terminate stimulation or misinterpret ambiguous findings, leading to inconsistent diagnoses. Operational criteria focusing on morphology, amplitude, duration, time lag from stimulus onset, and repetition across multiple frequencies could offer a more objective framework. This approach parallels other EEG elements that have benefited from standardized definitions, illustrating the potential to improve interrater reliability through uniform guidelines. Establishing clear operational criteria for PPR interpretation is vital for consistent diagnosis, research comparability, and optimized clinical care. A concerted effort from the epilepsy community to implement and refine these criteria would help resolve the current variability, ensuring that individuals with potential photosensitivity receive accurate assessment and appropriate management.
- 18 March 2026
- Published by Georg Thieme Verlag KG in International Journal of Epilepsy
Open AccessThe Need for Operational Criteria to Standardize Photoparoxysmal Response Interpretation: A Commentary
The photoparoxysmal response (PPR) is an epileptiform electroencephalographic (EEG) phenomenon triggered by intermittent photic stimulation. It is used to assess photosensitivity in individuals with epilepsy. However, wide variations in interpretation and inconsistent methodological practices have led to unreliable detection and classification of PPR, potentially affecting the management of photosensitive epilepsy. In regions with limited resources, the lack of standardized protocols, challenges with EEG equipment, and restricted access to specialized training further exacerbate diagnostic uncertainty. Despite multiple efforts to create guidelines for intermittent photic stimulation, the interpretation of PPR remains highly subjective, with only fair to moderate interrater agreement even among experienced specialists. One principal point of contention is differentiating truly stimulus-evoked activity from spontaneous epileptiform discharges. This ambiguity is clinically significant because determining photosensitivity influences lifestyle recommendations and treatment choices. Current classification systems for PPR establish broad categories of abnormal EEG activity, but they lack detailed operational criteria. There is no universal rule for the minimal duration of an abnormal discharge or the acceptable delay from stimulus onset. Additionally, narrowly incrementing photic stimulation frequencies may not always clarify borderline discharges. As a result, technicians and clinicians may prematurely terminate stimulation or misinterpret ambiguous findings, leading to inconsistent diagnoses. Operational criteria focusing on morphology, amplitude, duration, time lag from stimulus onset, and repetition across multiple frequencies could offer a more objective framework. This approach parallels other EEG elements that have benefited from standardized definitions, illustrating the potential to improve interrater reliability through uniform guidelines. Establishing clear operational criteria for PPR interpretation is vital for consistent diagnosis, research comparability, and optimized clinical care. A concerted effort from the epilepsy community to implement and refine these criteria would help resolve the current variability, ensuring that individuals with potential photosensitivity receive accurate assessment and appropriate management.
- 10 May 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (4) , 688-692
Absence‐to‐bilateral‐tonic–clonic seizure with focal features: A diagnostic challenge
- 10 May 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (4) , 688-692
Absence‐to‐bilateral‐tonic–clonic seizure with focal features: A diagnostic challenge
- Open Access
- 7 March 2025
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 10, 84-89
Two-year experience of a newly established epilepsy monitoring unit in a resource-limited setting
- 7 March 2025
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 10, 84-89
Open AccessTwo-year experience of a newly established epilepsy monitoring unit in a resource-limited setting
- 4 January 2025
- Published by Springer Nature
- p. 399-407
Comparison of Entropy Values in EEG of Patients with Juvenile Myoclonic Epilepsy and Healthy Individuals
- 4 January 2025
- Published by Springer Nature
- p. 399-407
Comparison of Entropy Values in EEG of Patients with Juvenile Myoclonic Epilepsy and Healthy Individuals
- 2 December 2024
- Published by Editora Nomada
- p. 279-306
Principios básicos de la neurobiología del sueño
Una mirada a las neurociencias II: procesos básicos y aplicaciones, coordinado por investigadores de la Academia de Neurociencias del Centro Universitario de los Valles, representa una valiosa compilación de capítulos destinados a difundir los últimos avances en el campo de las neurociencias, con el objetivo de hacer accesible este conocimiento tanto a estudiosos del tema como a estudiantes que están dando sus primeros pasos en esta fascinante disciplina. Los capítulos del libro tratan de tópicos de interés y especialidad de los autores que contribuyeron a la obra y abarcan temas que van del nivel celular hasta un nivel más amplio, desde temáticas propias de la ciencia básica como de las aplicaciones de la neuropsicología.
- 2 December 2024
- Published by Editora Nomada
- p. 279-306
Principios básicos de la neurobiología del sueño
Una mirada a las neurociencias II: procesos básicos y aplicaciones, coordinado por investigadores de la Academia de Neurociencias del Centro Universitario de los Valles, representa una valiosa compilación de capítulos destinados a difundir los últimos avances en el campo de las neurociencias, con el objetivo de hacer accesible este conocimiento tanto a estudiosos del tema como a estudiantes que están dando sus primeros pasos en esta fascinante disciplina. Los capítulos del libro tratan de tópicos de interés y especialidad de los autores que contribuyeron a la obra y abarcan temas que van del nivel celular hasta un nivel más amplio, desde temáticas propias de la ciencia básica como de las aplicaciones de la neuropsicología.
- Open Access
- 28 June 2024
- Published by Universidad Peruana Cayetano Heredia in Revista de Neuro-Psiquiatría
- Vol. 87 (2) , 181-193
Estimulación luminosa intermitente durante el electroencefalograma en epilepsia. Necesidad de homogeneizar su práctica en Hispanoamérica
La estimulación luminosa intermitente (ELI) es una de las maniobras más comunes y conocidas utilizadas durante los registros de electroencefalograma (EEG). A pesar de ser la de más fácil estandarización, presenta una gran variabilidad metodológica y la interpretación y clasificación de la respuesta fotoparoxística (RFP) sigue siendo, en gran medida, subjetiva. Objetivo: La presente revisión intenta ofrecer un marco de referencia actualizado acerca de la metodología estandarizada para la ejecución de la ELI y para interpretar/clasificar la RFP. Se formula un análisis crítico de los retos prácticos actuales en el ámbito clínico y se proponen algunos criterios operativos que pueden contribuir a mejorar el acuerdo entre evaluadores. Conclusiones: Los criterios operativos propuestos abarcan —pero no se limitan— a la morfología, la amplitud, la duración, el desfase y la redundancia. La generalización del uso de una metodología estandarizada de ELI, aunada a criterios operativos para confirmar la presencia de RFP, puede ayudar a mejorar el diagnóstico de epilepsia y de fotosensibilidad. De esta forma, la práctica clínica del EEG no solo mantendría su vigencia, sino que incluso mejoraría la atención a pacientes con epilepsia. La presente revisión en idioma español puede contribuir a homogeneizar esta práctica clínica en países hispanohablantes. Desarrollo: La presente revisión pretende ofrecer un marco de referencia actualizado acerca de la metodología estandarizada para realizar la maniobra de ELI y para interpretar/clasificar la respuesta fotoparoxística. Además, se hace un análisis crítico de los retos prácticos actuales con los que nos encontramos en el ámbito clínico diario y se proponen algunos criterios operativos que pueden contribuir a mejorar el acuerdo entre evaluadores. Conclusiones: Los criterios operativos propuestos son, pero no limitados a: la morfología, la amplitud, la duración, el desfase y la redundancia. La generalización del uso de una metodología de ELI estandarizada, aunada a criterios operativos para confirmar la presencia de RFP, puede ayudar a mejorar el diagnóstico de epilepsia y de fotosensibilidad. De esta forma, la práctica clínica del EEG no solo mantendría su vigencia, sino que incluso mejoraría la atención de los pacientes con epilepsia. Finalmente, creemos que esta revisión en idioma español puede contribuir a homogeneizar la práctica clínica en países hispanohablantes.
- 28 June 2024
- Published by Universidad Peruana Cayetano Heredia in Revista de Neuro-Psiquiatría
- Vol. 87 (2) , 181-193
Open AccessEstimulación luminosa intermitente durante el electroencefalograma en epilepsia. Necesidad de homogeneizar su práctica en Hispanoamérica
La estimulación luminosa intermitente (ELI) es una de las maniobras más comunes y conocidas utilizadas durante los registros de electroencefalograma (EEG). A pesar de ser la de más fácil estandarización, presenta una gran variabilidad metodológica y la interpretación y clasificación de la respuesta fotoparoxística (RFP) sigue siendo, en gran medida, subjetiva. Objetivo: La presente revisión intenta ofrecer un marco de referencia actualizado acerca de la metodología estandarizada para la ejecución de la ELI y para interpretar/clasificar la RFP. Se formula un análisis crítico de los retos prácticos actuales en el ámbito clínico y se proponen algunos criterios operativos que pueden contribuir a mejorar el acuerdo entre evaluadores. Conclusiones: Los criterios operativos propuestos abarcan —pero no se limitan— a la morfología, la amplitud, la duración, el desfase y la redundancia. La generalización del uso de una metodología estandarizada de ELI, aunada a criterios operativos para confirmar la presencia de RFP, puede ayudar a mejorar el diagnóstico de epilepsia y de fotosensibilidad. De esta forma, la práctica clínica del EEG no solo mantendría su vigencia, sino que incluso mejoraría la atención a pacientes con epilepsia. La presente revisión en idioma español puede contribuir a homogeneizar esta práctica clínica en países hispanohablantes. Desarrollo: La presente revisión pretende ofrecer un marco de referencia actualizado acerca de la metodología estandarizada para realizar la maniobra de ELI y para interpretar/clasificar la respuesta fotoparoxística. Además, se hace un análisis crítico de los retos prácticos actuales con los que nos encontramos en el ámbito clínico diario y se proponen algunos criterios operativos que pueden contribuir a mejorar el acuerdo entre evaluadores. Conclusiones: Los criterios operativos propuestos son, pero no limitados a: la morfología, la amplitud, la duración, el desfase y la redundancia. La generalización del uso de una metodología de ELI estandarizada, aunada a criterios operativos para confirmar la presencia de RFP, puede ayudar a mejorar el diagnóstico de epilepsia y de fotosensibilidad. De esta forma, la práctica clínica del EEG no solo mantendría su vigencia, sino que incluso mejoraría la atención de los pacientes con epilepsia. Finalmente, creemos que esta revisión en idioma español puede contribuir a homogeneizar la práctica clínica en países hispanohablantes.
- Open Access
- 13 June 2024
- Published by AccScience Publishing in Advanced Neurology
- Vol. 3 (2) , 3359
Unraveling genetic contributions to neurodevelopmental disorders and epilepsy in a pediatric cohort from a Mexican state
Neurodevelopmental disorders (NDDs) encompass a broad spectrum of conditions that significantly impact personal, social, academic, or occupational functioning from an early age. Epilepsy emerges as a significant comorbid condition, featuring a complex interplay between neurodevelopmental processes and epileptogenesis, likely rooted in genetic abnormalities. This research is a descriptive observational study designed to assess the contribution of genetic variations to the clinical presentation of NDDs in a pediatric population from the Mexican state of Jalisco, aiming to enhance diagnostic and management strategies. The patients underwent comprehensive clinical evaluations and personalized genetic testing using next-generation sequencing techniques, and their relatives were studied only on a case-by-case basis if information regarding the mode of inheritance was needed. This study included 24 patients and 30 relatives. Diagnoses of Mendelian inheritance diseases were identified in 14 patients, including cases with mutations not previously associated with NDDs. Genetic testing revealed a variety of pathogenic and likely pathogenic mutations, as well as variants of uncertain significance, across a range of genes implicated in NDDs. Notable findings included new mutations related to low-prevalence genetic syndromes and the identification of both inherited and de novo mutations contributing to the neurodevelopmental phenotypes observed. Our findings underscore the complex genetic landscape of NDDs and epilepsy, highlighting the crucial role of genetic evaluation in elucidating the etiology of these disorders within the studied population. The integration of genetic testing into the diagnostic process for NDDs not only facilitates a more precise diagnosis but also informs prognostic outlooks and guides tailored intervention strategies. Moreover, this study advocates for the continued exploration of genetic underpinnings in NDDs to further refine diagnostic accuracy, improve therapeutic approaches, and support familial decision-making, and emphasizing the importance of genetics in advancing neurodevelopmental medicine.
- 13 June 2024
- Published by AccScience Publishing in Advanced Neurology
- Vol. 3 (2) , 3359
Open AccessUnraveling genetic contributions to neurodevelopmental disorders and epilepsy in a pediatric cohort from a Mexican state
Neurodevelopmental disorders (NDDs) encompass a broad spectrum of conditions that significantly impact personal, social, academic, or occupational functioning from an early age. Epilepsy emerges as a significant comorbid condition, featuring a complex interplay between neurodevelopmental processes and epileptogenesis, likely rooted in genetic abnormalities. This research is a descriptive observational study designed to assess the contribution of genetic variations to the clinical presentation of NDDs in a pediatric population from the Mexican state of Jalisco, aiming to enhance diagnostic and management strategies. The patients underwent comprehensive clinical evaluations and personalized genetic testing using next-generation sequencing techniques, and their relatives were studied only on a case-by-case basis if information regarding the mode of inheritance was needed. This study included 24 patients and 30 relatives. Diagnoses of Mendelian inheritance diseases were identified in 14 patients, including cases with mutations not previously associated with NDDs. Genetic testing revealed a variety of pathogenic and likely pathogenic mutations, as well as variants of uncertain significance, across a range of genes implicated in NDDs. Notable findings included new mutations related to low-prevalence genetic syndromes and the identification of both inherited and de novo mutations contributing to the neurodevelopmental phenotypes observed. Our findings underscore the complex genetic landscape of NDDs and epilepsy, highlighting the crucial role of genetic evaluation in elucidating the etiology of these disorders within the studied population. The integration of genetic testing into the diagnostic process for NDDs not only facilitates a more precise diagnosis but also informs prognostic outlooks and guides tailored intervention strategies. Moreover, this study advocates for the continued exploration of genetic underpinnings in NDDs to further refine diagnostic accuracy, improve therapeutic approaches, and support familial decision-making, and emphasizing the importance of genetics in advancing neurodevelopmental medicine.